REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPH and the CUSIP is 76152G100. A total of 13 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $222,908 | +117.4% | 53,200 | +120.5% | 0.03% | +120.0% |
| Q4 2022 | $102,531 | -92.2% | 24,125 | -98.0% | 0.02% | -92.5% |
| Q2 2022 | $1,320,000 | -55.3% | 1,200,000 | 0.0% | 0.20% | -66.2% |
| Q1 2022 | $2,952,000 | -14.9% | 1,200,000 | 0.0% | 0.59% | -15.2% |
| Q4 2021 | $3,468,000 | -29.0% | 1,200,000 | 0.0% | 0.70% | -31.3% |
| Q3 2021 | $4,884,000 | -16.3% | 1,200,000 | 0.0% | 1.01% | -12.7% |
| Q2 2021 | $5,832,000 | – | 1,200,000 | – | 1.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 564,000 | $2,752,320 | 0.84% |
| EMC Capital Management | 123,915 | $613 | 0.45% |
| Ikarian Capital, LLC | 5,095 | $2,486,360 | 0.30% |
| SABBY MANAGEMENT, LLC | 44,593 | $217,614 | 0.16% |
| ARMISTICE CAPITAL, LLC | 600,000 | $2,928,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 70,181 | $342 | 0.03% |
| Caption Management, LLC | 275,200 | $1,342,976 | 0.02% |
| Caption Management, LLC | 216,600 | $1,057,008 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 109,700 | $535,336 | 0.01% |
| J. Goldman & Co LP | 75,000 | $366,000 | 0.01% |